A critical discovery in cancer study is occurring with the use of mini-antibodies to reactivate damaged p53. This essential tumor protector protein is frequently disabled in various forms of tumors, causing https://bookmarkcitizen.com/story21928103/nanobodies-restore-the-p53-protein-the-promising-approach-for-tumor-management